Wednesday, 28 July 2021

Electric Transporters Market Analysis, Impact Of Covid-19 On Sales, Business Opportunities In 2021

The Global Electric Transporters Market Is Anticipated To Reach USD 69.5 Billion By 2026 According To A new study published by Polaris Market Research. Electric transporters that include all types of e-vehicles are the primary trend within the automobile industry. These products boost the energy efficiency, require no direct fuel combustion and rely completely on the most diversified energy source carrier (electricity) which contributes to a wide range of transport policy goals. Increasing use of electric transporters will lead to energy security, rising quality of air, lesser noise pollution, lesser emission of greenhouse gases in concert with low-carbon power generation mix.

 

Moreover, as e-vehicles are the trending innovating clusters in the automotive sector, these products have substantial potential to enhance industrial and economic competitiveness, hence attracting investments wherever major markets can be developed in the near future. Significant industry uptake of this segment of automobiles has occurred in the recent years. On- going commitments and support for further development of electric transporters from the automotive industry and policy makers suggest that the trend of EV will not abate in the next decade.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/electric-transporters-market/request-for-sample

 

The increasing sales volumes of electric transporters along with the growing competition in the development of noble technologies are most likely to contribute continuous reduction in manufacturing cost of batteries, which is the most primary cost component of e-transporters. These costs cutting EV technologies have further strengthen their competitiveness compared with the internal combustion engines. This reinforces the case for road e-vehicles that are continuously occupying an expanding market share and perhaps a leading role in the evolution of transportation across all modes.

 

The global industry is recently influenced by some of the major developments in the European Union, China, the U.S. and the India. In 2017, the EU, China and India that together accounted for roughly 60% of the worldwide LDV market proposed and later implemented significant changes in policies that are likely to accelerate the phase of e-transporters and share their deployment in a global scale. On the flip side of it, recently announced policies on the rollback of federal regulations on the fuel economy of cars in the U.S. are anticipated to have negative influence on the uptake of electric cars.

 

Asia Pacific was the leading regional market in 2017, with China accounting for the major share. In 2017 September, the Chinese government issued a newly framed energy vehicle credit mandate that took effect in 2018. This mandate sets a new and minimum benchmark for the production of electric transporters with some flexibility offered through credit trading mechanism. The country has emerged as the major hub for production of these products not only because of its supporting policy framework but also for its low cost production rates. Reflecting the cost difference in battery cost electric vehicles in the country are much less expensive. Application of lead acid batteries leads to an estimated cost of USD 167 of an electric bike in the country. On the contrary, these products cost at an average of USD 815 in the U.S. and an average cost of USD 1,546 in the Western Europe countries, which reflects to the different choices in the battery chemistry.

 

Special Discount Offer on Complete Report @ https://www.polarismarketresearch.com/industry-analysis/electric-transporters-market/request-for-discount-pricing

  

Some of the industry participants include F-wheel DYU, Fuji-Ta, Baidu, Airwheel, Goldenwheel, Robstep, Hybike, Bafang (8FUN) Motor, Geoby, Guewer, Benelli, BMW Bicycles, BH, ECO Movement, Electric Bike Plus, Fully Charged, Mahindra GenZe and Kalkhoff.

Pruritus Therapeutics Market Is Expected To See Huge Growth. Latest Research Report

 The global pruritus therapeutics market is anticipated to reach over USD 17,275.12 Million by 2026, according to a new research published by Polaris Market Research, Pruritus, also known as itch disorder can be triggered by several ailments ranging from dermatological disorders such as mycoses, atopic dermatitis, chickenpox, and contact dermatitis, Pruritus is interrelated with the dermatologic and systemic causes. A typical itching generally forms the diagnosis of a key dermatologic syndrome. Several skin diseases that are related to pruritus include renal pruritus, hematologic pruritus, cholestatic pruritus, idiopathic generalized pruritus, pruritus related to malignancy and endocrine pruritus. Renal pruritus can befall in people with chronic renal failure. Increased levels of ions such as calcium, phosphate, and magnesium are found in the skin of pruritic patients.  Severe pruritus leads to scratching that causes secondary skin problems such as eczematization, dryness, infection, excoriation, Contact allergy, and lichenification.

 

Some major key players in global Pruritus Therapeutics Market include pruritus therapeutics market includes Allergan Inc., Amgen Inc., Astellas Pharma Inc., CARA Therapeutics, Novartis AG, and Teva Pharmaceutical Industries Ltd. among others.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-sample

 

The rising incidence of dermatological disorder influencing the occurrence of pruritus and subsequently, the rising demand for proper diagnostics as well as therapeutics to treat the such medical condition is anticipated to bolster the market growth. The rise in inorganic development strategies is recognized as one of the key factor boosting the growth of the pruritus therapeutic market. In addition, the key players of the pruritus therapeutic market are progressively adapting the growth strategies such as partnerships, regional acquirements, and mergers and acquisitions. Such growth strategies are anticipated to result in technological advancement owing to enhancement in the product portfolio and mutual collaboration in R&D further boosting the market growth.

  

The global pruritus therapeutics market is segmented on the basis of product, disease type, and geography. On the basis of product, the global pruritus therapeutics market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others. In 2017, the corticosteroids are expected to dominate the market by product segment as corticosteroids are widely used as the first line of treatment. On the basis of disease type, the global pruritus therapeutics market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, and Others. In 2017, Allergic contact dermatitis is estimated to dominate the market segment. It is the 3rd most general cause for patients seeking consultation with a dermatology specialist. Allergic contact dermatitis is commonly observed in women.

 

Special Discount Offer on Complete Report @ https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market/request-for-discount-pricing

 

On the basis of region, the global pruritus therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global pruritus therapeutics market. The dominance is majorly due to The presence of favorable government initiatives and the introduction of new products. Moreover, rising incidence of target disorders and the existence of pruritus inducing climatic disorders in this region are anticipated to boost the market growth during the forecast period. However, Asia Pacific is anticipated to dominate pruritus therapeutics market. Growing incidence of atopic dermatitis and urticarial and presence of unmet healthcare organization needs are the factors attributed to the growth of the market in Asia Pacific.

 

Buy Now : https://www.polarismarketresearch.com/checkouts/2691

Private 5G Network Market Size, Share, Opportunities, In-Depth Analysis And Forecasts

 The global private 5G network market size is expected to reach USD 8.32 billion by 2027 according to a new study by Polaris Market Research. The report “Private 5G Network Market Share, Size, Trends, Industry Analysis Report, By Component Outlook (Hardware, Services); By Frequency (Sub-6 GHZ, mmWave); By Spectrum (Licensed, Unlicensed/Shared); By Vertical (Manufacturing, Energy & Utilities, Transportation & Logistics, Aerospace & Defense, Government & Public Safety, Enterprises, Mining, Healthcare, Oil & Gas, Others); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

A private 5G network is a cellular network which comprises of core network servers and cell sites to support the connectivity. Also, maximizes WAN connection to mobile end points.  In addition, this network provides features such as network slicing, far lower latency, superior bandwidth, among others. Moreover, a private 5G network provides industries with high-performing networks and helps in operations of several technologies such as automated guided vehicles (AGVs), drones, sensor technology, heavy machinery automation, robotics, and others. To address wireless communication requirements in operations of industries, public safety and others is leading to rise in demand of private 5G networks.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/private-5g-network-market/request-for-sample

 

Furthermore, in the wake of COVID-19 pandemic, the Wi-Fi hotspots are overloaded and the demand has increased significantly for higher capacity & data speeds. Therefore, incorporating of private 5G networks has increased among the private organization, regulators, manufacturers, and other potential users globally.

 

 

Factors such as demand & applications for real-time based networking and Time-sensitive Networking (TSN) has tremendously increased among several industry vertical such as oil & gas, manufacturing, aerospace, and transportation. Thus, due to this increased application & technological development are fueling the demand for private 5G network and is expected to witness significant growth during the forecast period.

 

Market participants such as Altiostar, AT&T Inc., Broadcom Inc., Cisco Systems, Deutsche Telekom, Huawei Technologies Co, Nokia Corporation, Qualcomm Technologies, Inc., Samsung, Telefonaktiebolaget LM Ericsson, T-Systems International GmbH, Verizon Communications, Vodafone Limited, and ZTE Corporation are some of the key players operating in the global market.

 

Players in the market are focusing on developing new products and partnering with industrial manufacturers to establish a private 5G network-based devices on a private 5G network within the geographic footprint. For instance, in July 2020, Nokia has launched a commercial 5G standalone private wireless networking solution for businesses in the marketplace that would accelerate digitalization in different sectors.

 

Have Questions? Inquiry before buying this report by clicking the following link : https://www.polarismarketresearch.com/industry-analysis/private-5g-network-market/speak-to-analyst

 

Cisco introduced Premium Mobile Broadband (PMB) is a private LTE solution that delivers high-speed mobility and allows security for mobile roaming. Accenture and AT&T has developed a private cellular network solution for manufacturing, energy, and logistics for multinational Phillips 66.

 

https://www.prnewswire.com/news-releases/private-5g-network-market-size-is-projected-to-reach-13-92-billion-by-2028--cagr-40-9-polaris-market-research-301258477.html

Car T Cell Therapy Market 2021 Booming Strategies Of Top Companies

 The global CAR-T Cell Therapy market size is expected to reach USD 15.4 billion by 2028 growing at a CAGR of 34.2% from 2021 to 2028 according to a new study published by Polaris Market Research. The report “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Regions: Segment Forecast, 2021 – 2028” provides deep dive insights on the current market dynamics and gives a detailed analysis on future growth trends of this market.

 

This market report focuses on CAR-T which is one of the most innovative therapy available in the market which uses the patients’ immune cells to fight cancer. The WBCs (white blood cells) are extracted – reengineered – injected again into the patient body to fight the malignant cells. This novel therapy has joined the bandwagon of the cancer cure treatments and it is expected to be one the sought-after therapies in the market. Majority of the companies have already started investing in them to gain a better market share in this industry.

 

Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample

 

According to the analysis by Polaris Market Research, the potential of the market is ~ $15 billion by 2028, with major focus on Diffuse Large B-Cell Lymphoma (DLBCL) indication in 2020-21. However, it is expected that the market would also start focusing on Multiple Myeloma (MM) indication and the market for the same is expected to grow at a compounded annual growth rate of more than 46% from 2021 to 2028.

 

It is estimated that U.S. is one of the major markets for CAR-T Cell Therapy due to continuous R&D happening in this region also backed by ongoing regulatory approvals of the new therapies. Along with the new therapy developments, companies are also focusing on establishing centers for cancer awareness and how this novel therapy would help in cancer treatment. This would help the market to grow in this region. The European region is also expected to closely follow by U.S. wherein European Medicine Agencies (EMA) have approved Kymriah and Yescarta which is expected to push the market for further growth in this region. However, the market for Asia Pacific is at its early stages wherein Ministry of Health, Labor and Welfare (MHLW) of Japan is the first regulatory authority to approve Kymriah in APAC.

 

It can be seen that the business scenario of the market is dynamic and major companies are competing with each other to increase their market share in the major geographies of U.S. and Europe. For example, Novartis and Gilead came-up with 33 and 28 authorized centers respectively in U.S. Some of the major companies in this space such as Celgene are expected to file for FDA approvals for two more CAR-Ts lisocabtagene maraleucel in lymphoma and bb2121 (idecabtagene vicleucel) in myeloma.

 

If you have any special requirements, please let us know and we will offer you the report as you want. Place your Quiry Here! https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/speak-to-analyst

 

Along with opening new centers and acquiring necessary government approvals, the companies are also focusing on partnerships, acquisitions and mergers. For instance, Celgene acquired Juno Therapeutics in November 2018 for approximately $9 billion in 2018 and further Bristol-Myers Squibb completed its acquisition of Celgene in November 2019.

 

Some major key players in global CAR-T Cell Therapy Market includes Bluebird Bio (US), Celgene Corporation (US), Gilead Sciences, Inc. (US), Cellectis (France), Servier Laboratories (France), Pfizer Inc. (US), Mereck KGaA (Germany), Amgen Inc. (US), Intellia Therapeutics (US), Novartis International AG (Swiss), Caribou Biosciences, Inc. (US), Celyad (Belgium), Bellicum Pharmaceuticals, Inc. (US), Noile-Immune Biotech (Japan), Nanjing Legend Biotechnology Co., Ltd. (China), Johnson & Johnson (US), Sangamo Therapeutics, Inc. (US) among others.

 

Polaris Market research has segmented the CAR-T Cell Therapy market report on the basis of Target Antigens, Indications, and Region

 

CAR-T Cell Target Antigens Outlook (Revenue, USD Million, 2017 – 2028)

  • CD19/CD22
  • BCMA (B-Cell Maturation Antigen)
  • Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Rα2, LewisY)

CAR-T Cell Indication Outlook (Revenue, USD Million, 2017 – 2028)

  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Multiple Myeloma (MM)
  • Follicular Lymphoma (FL)
  • Others

CAR-T Cell Regional Outlook (Revenue, USD Million, 2017 – 2028)

  • U.S.
  • Europe
  • Japan
  • Rest of the World

Read More : 

https://www.prnewswire.com/news-releases/closed-system-transfer-device-market-size-to-surpass-1-91-billion-by-2028--cagr-20-1-polaris-market-research-301294657.html

https://www.prnewswire.com/news-releases/global-covid-19-vaccine-packaging--delivery-devices-market-size-us-3-58-billion-by-2028--cagr-20-1-pmr-301297573.html

https:/www.prnewswire.com/news-releases/pea-starch-market-size-worth-150-7-million-by-2028--cagr-7-2-polaris-market-research-301306705.html

 

Tuesday, 27 July 2021

Smart TV Market Analysis, Impact Of Covid-19 On Sales, Business Opportunities In 2021

Global Smart TV Market: Trending in 2021

 

According to a new study published by Polaris Market Research the smart TV market is anticipated to reach USD 341.6 billion by 2026. In 2017, the Full HD Smart TV segment dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period.

 

The increasing adoption of 4K televisions, and growing penetration of high speed internet have boosted the adoption of smart TVs. Increasing disposable incomes, and growth in media & entertainment industry further support the growth of this market. Increasing penetration of televisions, growing demand for superior video and audio television content, and rising consumption of online content boost the adoption of smart TVs. Increasing investments by vendors in technological advancements coupled with increasing demand from emerging economies further boost the market growth.

 

The growing disposable income has encouraged consumers to buy technologically advanced television sets that are in perfect amalgamation with their increasing living standards. Moreover, consumers are opting for high quality video and audio services along with the ability to connect to the internet. Thus, lofty living standards and increasing consumption of online content, would contribute to the growth of the smart TV market, thereby positively affecting the market growth.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/smart-tv-market/request-for-sample

 

Asia-Pacific generated the highest revenue in the market in 2017 and is expected to lead the global market throughout the forecast period. The increasing disposable incomes in developing countries of this region, and growing media and entertainment industry drive the market growth in the region. There has been a significant increase in the shipment of smart TVs in the region. The growing demand for high quality audio and video services, along with the need to connect to the internet has encouraged consumers to invest in smart TVs. Local players are introducing low cost Smart TVs with advanced technologies to cater to the growing demand of consumers. Numerous key players have adopted partnership and expansion strategies to increase their market share in Smart TV markets of the Asia-Pacific region.

 

The different ranges of screen sizes covered in the report include 28 to 40 Inches, 41 to 59 Inches, and above 60 Inches. In 2017, the 41 to 59 inches segment accounted for the highest market share. Smart TVs with screen sizes in the range of 41 to 59 inches are gaining traction worldwide owing to improved capability to offer superior video and audio quality along with additional features. Introduction of low cost smart TVs by the market players have boosted the growth of this market segment.

 

Buy Now : https://www.polarismarketresearch.com/checkouts/871

 

The well-known companies profiled in the report include LG Electronics, Inc., Koninklijke Philips N.V., Sony Corporation, Samsung Electronics Co. Ltd., Sharp Corporation, Hitachi Ltd., Toshiba Corporation, Haier Electronics Group Co., Ltd., Panasonic Corporation, Videocon Industries Limited, and Skyworth Digital Holdings Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Pea Starch Market Comprehensive Research Including Top Companies, Latest Trends

 The global pea starch market size is expected to reach USD 150.7 million by 2028 according to a new study by Polaris Market Research. The report “Pea Starch Market Share, Size, Trends, Industry Analysis Report, By Type (Organic, Traditional); By Application (Gelling, Film Foaming, Binding & Thickening, Texturizing); By End-Use (Food & Beverages, Animal Feed, Pet Food, Cosmetics, Pharmaceutical, Textile); By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The market is projected to witness growth over the forecast period owing to increasing demand for convenience food, hectic consumer lifestyle, and rising application in animal feed. The consumption of pea starch has also increased on account of the growing disposable income of consumers, increasing health concerns, and rising awareness regarding nutrition and fitness. Companies are introducing pea starch-based food products to enable consumers to maintain weight, provide nutritional requirements, and align with their health goals.

 

There has been an increasing shift towards the consumption of organic products. In August 2019, Cargill invested $75 million in PURIS to strengthen its offerings of pea proteins, starches, and fibers. This would enable the company to address the growing consumer demand for plant-based proteins to fulfill their nutritional needs. PURIS offers a wide portfolio of non-GMO and organic pea starch for multiple food and beverage categories.

 

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/pea-starch-market/request-for-sample

 

The end-use for the market includes food & beverages, animal feed, pet food, cosmetics, pharmaceutical, textile, and others. The food & beverage industry uses pea starch in a wide range of products such as dairy, baked goods, meat products, soups, and canned goods. Increasing health concerns among adults as well as kids drive the growth of this segment.

 

Increasing consciousness towards physical appearance and fitness coupled with a hectic lifestyle has increased the demand for healthy snacks and meal replacements, supplementing the growth. The pet food segment is expected to experience significant growth during the forecast period owing to the shift towards grain-free pet food. Pea starch is increasingly being used in wet and dry pet food, snacks, and treats.

 

The applications of pea starch include gelling, film foaming, binding and thickening, texturizing, and others. The gelling segment accounted for the highest share in 2019. The growth in the convenience food industry is expected to drive the market in this segment during the forecast period.

 

Pea starch is a major component in food products that require an elastic texture owing to its high amylose content. Growing industrial applications of pea starch for gelling, coupled with increasing demand from the animal feed sector are factors expected to provide numerous growth opportunities in the coming years.

 

Get Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/pea-starch-market/request-for-discount-pricing

 

Asia Pacific is expected to exhibit significant growth during the forecast period. Population growth, rising disposable incomes, and growing use in food products such as bakery, dairy, and confectionery drive the market growth in the region.

 

The population in the region is gradually moving from traditional food groups to a range of healthier food options and is willing to spend more on food that offers high nutritional value. With increasing consciousness regarding diet and lifestyle among youth, the market is expected to grow significantly in the coming years.

 

Some of the major market participants include Parrish and Heimbecker, Ltd., Axiom Foods, Inc., Dakota Dry Bean, Puris Foods, Vestkorn Milling AS, Roquette Freres, Meelunie B.V., AGT Food and Ingredients, Shandong Jianyuan Group, Emsland Group, Yantai Shuangta Food Co., Ltd., Cosucra Groupe Warconing SA, Felleskjøpet Rogaland Agder, and the Scoular Company.

 

Scaffold Technology Market 2021 Booming Strategies Of Top Companies

 The global scaffold technology market  size is expected to reach USD 2.22 billion by 2028 according to a new study by Polaris Market Research. The report “Global Scaffold Technology Market Share, Size, Trends, Industry Analysis Report, By Type (Hydrogels {Wound Healing, 3D Bioprinting, Immunomodulation}, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); By Application; By Disease Type; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The recent advancements in micro-molding, photo-lithography, and stereo-lithography also driving scaffolding technology. For instance, the innovations in injectable and microporous hydrogels also enabled organ on a chip technology to enhance in-vivo healing. Moreover, ongoing advancements in micro-fabrication technology are also projected to boost the market growth.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/scaffold-technology-market/request-for-sample

 

In 2020, the hydrogels market segment of scaffold technology industry had the largest revenue share. This high share is attributed to the excellent properties of hydrogels, such as controlled drug delivery, and ease of loading drugs. In current times, hydrogels have gained momentum and are regarded as a leading candidate in 3D cell cultures and tissue engineering.

 

The nanofiber scaffolds segment is projected to show the fastest growth rate over the assessment period. Nanoscale fibrous structures with inter-connecting pores facilitate the formation of artificial tissues during the process of tissue engineering. Artificial tissues resemble natural ones, by providing an extracellular matrix of the living tissues.

 

Market participants such as Merck KGaA, Molecular Matrix, Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific, Xanofi, REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, and Medtronic. are some of the key players operating in the global market for scaffold technology.

 

Get Offer :  https://www.polarismarketresearch.com/industry-analysis/scaffold-technology-market/request-for-discount-pricing

 

Players in the marketplace are collaborating with small players to stay competitive in the market for scaffold technology. For instance, in October 2019, Avacta Life Sciences collaboration agreement with ADC Therapeutics to develop Affimer drug conjugates, to use in biological scaffolds.

 

Read More : https://www.prnewswire.com/news-releases/scaffold-technology-market-size-worth-2-22-billion-by-2028--cagr-9-1-polaris-market-research-301243229.html?tc=eml_cleartime

 

Theranostics Market Analysis, Impact Of Covid-19 On Sales, Business Opportunities In 2021

 The Global Theranostics Market Size Is Anticipated To Reach Over USD 20.52 Billion By 2026 According to a new study published by Polaris Market Research.

 

Theranostics are defined as a combination of diagnostics and drug therapeutics to improve the drug safety, drug restructures development and effectiveness. The combination of effective medical drugs and advanced diagnostic tests has been given numerous names, such as Dx/Rx partnering, integrated medicine, pharmacodiagnostics, and companion diagnostics.

 

Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market/request-for-sample

 

The increasing occurrence of life-threatening and chronic diseases and the demand for innovative chemotherapeutic treatments associated with the need for improving disease detection are the key factors propelling the global theranostics market. In addition, the rising potential of clinically adaptable nanomaterials in the biological imaging area and therapy is expected to bolster the market growth. Moreover, improved collaboration between drug and diagnostics firms are anticipated to enhance the growth of the theranostics market. In addition, a decrease in costs and reduced time required for medical trials monitored by pharmaceutical segments are another key drivers propelling the growth of the global theranostics market.

  

The global theranostics market is segmented on the basis of disease type, technology, and geography. On the basis of disease type, the global theranostics market is segmented into Neurological Disorders, Cardiovascular Diseases, Oncology Disorders, and Immunological Disorders. On the basis of disease type, the oncology segment is anticipated to boost the market growth. Increasing cancer cases and theranostics potentials to make effective cancer care are the factors associated with the market growth.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/global-theranostics-market/request-for-discount-pricing

 

On the basis of technology, the global theranostics market is segmented into Polymerase Chain Reaction (PCR), In-situ Hybridization, Immunohistochemistry, and sequencing. In 2017, the PCR is anticipated to dominate the market growth. The existence of a robust evaluate assortment in terms of polymerase chain reaction (PCR) is accountable for the larger market share.

 

Some major key players in global theranostics market include F Hoffman La Roche, Thermo Fisher Scientific Inc., GE Healthcare, Agilent Technologies, Qiagen NV, Foundation Medicine, Leica Biosystems Nussloch GmBH, and Pfizer, Inc. among others.

 

Buy Now : https://www.polarismarketresearch.com/checkouts/2631

Anti-Drone Market Size, Share, Opportunities, In-Depth Analysis And Forecasts

 According to a new study published by Polaris Market Research the worldwide anti-drone market is anticipated to reach over USD 3,064 million by 2026. In 2017, the defense and military segment dominated the global market, in terms of revenue. North America is expected to be the leading contributor to the global market revenue during the forecast period.

 

The rising incidences of misuse of drones and growing terrorist activities primarily drive the growth of this market. Smugglers and traffickers are increasingly using drones for malicious and criminal activities, thereby increasing the demand of anti-drones. Other driving factors include technological advancement, and increasing investment in R&D.

 

Get Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/anti-drone-market/request-for-sample

 

There has been an emerging threat from drones to critical infrastructure. A high number of cases of drone overflights at nuclear and power stations have been registered. In 2014, after several cases of overflights of reactors, French authorities invested $1.1 million for detection, identification, and neutralization of small aerial drones.

 

There has been a significant increase in spoofing and cyber-attacks. Spoofing is taking control of a drone by hacking the radio signal and sending commands to the aircraft from another control station. Valuable data can be stolen or deleted through cyber-attacks. Complaints registered against misuse of drones also include snooping, burglary, smuggling contraband into prisons, and mid-air near misses among others. Terrorists have started using drones to gather valuable intelligence on their enemies. All these factors have increased the adoption of anti-drone systems.

 

North America generated the highest revenue in the market in 2017, and is expected to lead the global market throughout the forecast period. The driving factors for anti-drone market in North America include increasing number of security breach incidents by unidentified drones and increasing terrorist activities. Recent incidences of riots & civil unrest have increased the demand for anti-drones in this region. North America spends high budgets for military expenditure and for research & development programs, which augment market growth.

 

Get Discount Offer @ https://www.polarismarketresearch.com/industry-analysis/anti-drone-market/request-for-discount-pricing

 

The various end-users of anti-drones include defense and military, government, commercial, and others. In 2017, the defense and military sector accounted for the largest share in the global market, and is expected to maintain its lead during the forecast period. The demand for anti-drones in the military sector has increased owing to growing cases of smuggling, trespassing, and spying. Increasing need for border security, and threats from neighboring countries support the adoption of anti-drones.

 

The well-known companies profiled in the report include Saab AB, Thales Group, Raytheon Co., Lockheed Martin Corp. , Dedrone Inc, Droneshield Ltd., Northrop Grumman Corp., Theiss UAV Solutions, LLC, Blighter Surveillance Systems Ltd., Israel Aerospace Industries Ltd.,  among others. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Buy Now @ https://www.polarismarketresearch.com/checkouts/191

5g Infrastructure Market Size, Share, Opportunities, In-Depth Analysis And Forecasts

 The global 5G Infrastructure market size is expected to reach USD 47.6 billion by 2027 according to a new study by Polaris Market Research. 5G infrastructure is an advanced technology for a mobile broadband network and a combination of Radio Access Network (RAN), core network, and backhaul & transport. It supports the future internet (FI) and provides the ultra-high broadband infrastructure for several industry vertical including manufacturing, healthcare, and automotive. With supporting high-speed internet services, 5G infrastructure helps in undertaking futuristic necessities and creates an atmosphere to facilitate socio-economic changes in the market.

 

Industries in the Europe region are ready for this change, when 3G arrived, companies mobilized their workforce, 4G started digitizing their work processes and value chain. Nowadays, industries already set up digitization pathways, enabling real time consensus between suppliers and customers through digital transformation achieved through cutting edge communication network, bolstering productivity, while keeping data secure. To capitalize on the ongoing course of evolution the industries need to focus on innovative service, sustainable market investment, promoting digital champions, reforms in spectrum policies, and regulated access to fiber backhaul.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/5g-infrastructure-market/request-for-sample

 

Furthermore, the outbreak of COVID-19 has dramatically changed the prospects for 5G infrastructure across the globe. In addition, several applicable verticals have jolted resulting in a supply chain disruption causing slowdown in production. However, to regain profitability & continue production, the market is expected to grow significantly in the upcoming year.

 

With advancements in the field of telecommunications, especially in mobile networks; the demand for 5G infrastructure has increased tremendously. The development of several industries succeeded with the use of 4G technologies across various sectors is one of the factor propelled market growth. Moreover, the rise in demand for enhanced bandwidth connectivity with low latency for several applications including drone connectivity and vehicle to everything (V2X) is projected to fuel the market growth.

 

Market participants such as Nokia Corporation, Telefonaktiebolaget LM Ericsson, Huawei Technologies Co., Ltd., Comba Telecom Systems Holdings Ltd., ZTE Corporation, Cisco Systems, Inc., Fujitsu Limited, CommScope Inc., Casa Systems, Samsung Electronics, Altiostar, NEC Corporation, Airspan Networks, HPE, Mavenir, Ceragon, Aviat Networks, Inc., Parallel Wireless, JMA Wireless are some of the key players operating in the global market.

 

Have some specific queries about this report, our team of analyst will be glad to help! Click here : https://www.polarismarketresearch.com/industry-analysis/5g-infrastructure-market/speak-to-analyst

 

 Key players in the market are focusing on launching new products, executing partnership, developing existing offering, and have adopted various strategies to expand their foothold in the market. In July, 2020, NEOM, the cross border smart city in Saudi Arabia signed contract with the STC group for establishing the 5G infrastructure. The contract would accelerate its digital ambitions, starting with the innovation center.

Intravenous Immunoglobulin Market Size, Share, Opportunities, In-Depth Analysis And Forecasts

 The global intravenous immunoglobulin market size is anticipated to reach over USD 16,882.15 Million by 2026, according to a new research published by Polaris Market Research 

 

Immunoglobulins (IGs) are glycoproteins that are formed in the blood plasma in response to the antigens (Ag), which are considered as a foreign material to the host system. IGs are highly composite objects and precise in their nature. They are achieved from blood by fractionation procedure and filtered fo non-therapeutic as well as therapeutic applications. In therapeutics, they are administered intravenously for the treatment of several immunodeficiency.

 

The global intravenous immunoglobulin market majorly is driven by rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. 

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-sample

  

Moreover, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from PID globally. Rising occurrences of these immune diseases is anticipated to bolster the demand for intravenous immunoglobulin treatments during the forecast period. The demand for IVIG treatments for the primary and acquired immunodeficiency disorder is growing as it is the only available as well as most effective treatment option. Moreover, inactive lifestyle behaviors, including intake of saturated fats, sugars and salts, less physical actions, and high alcohol intake have led to the surge in the occurrence of such diseases. Increasing occurrence of such lifestyle related disease including antibody deficiency disorders and obesity are the factors anticipated to drive the global intravenous immunoglobulin market growth.

  

The global intravenous immunoglobulin market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP). In 2017, Hypogammaglobulinemia is estimated to dominate the application segment. The dominancy is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease are estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.

 

Get Discount Offer: https://www.polarismarketresearch.com/industry-analysis/global-intravenous-immunoglobulin-market/request-for-discount-pricing

 

Some major key players in global intravenous immunoglobulin market include Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.